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Wound repair is a complex biologic process which becomes abnormal in numerous disease states. Although in vitro models have
been important in identifying critical repair pathways in speciﬁc cell populations, in vivo models are necessary to obtain a more
comprehensive and pertinent understanding of human wound healing. The laboratory mouse has long been the most common
animal research tool and numerous transgenic strains and models have been developed to help researchers study the molecular
pathways involved in wound repair and regeneration. This paper aims to highlight common surgical mouse models of cutaneous
disease and to provide investigators with a better understanding of the beneﬁts and limitations of these models for translational
applications.
1.Introduction
Impairments in wound healing constitute an enormous
biomedical burden and cause a signiﬁcant degree of global
morbidity and mortality [1–3]. Aberrations in the normal
biological response to cutaneous injury following disease,
trauma, and surgery inevitably lead to signiﬁcant compli-
cations. The wound repair process is extremely complex
and the underlying pathophysiology of chronic wounds and
ﬁbrotic disease is often multifactorial [4]. Our incomplete
understanding of the molecular, cellular, and physiologic
mechanisms governingwound healing accounts for theoften
disappointing results of modern therapies.
The predominant cell populations in mammalian skin
are ﬁbroblasts and keratinocytes. Accordingly, the vast
majority of in vitro wound healing studies utilize either one
or both of these cell types. The study of cellular behavior in a
two-dimensional culture dish oﬀers the ability to investigate
speciﬁc targets with minimal interference from external
factors, but critical in vivo cues (paracrine signaling, three-
dimensional cues, etc.) are missing and thus limit the trans-
lational applicability of in vitro studies. In vitro coculture
experiments partially address the importance of paracrine
interactions between diﬀerent skin cell populations [5],
but are also limited in their biological relevance to wound
healing.
Increasingly complex “organotypic” systems have been
developed to better recapitulate the native skin environment
[6].These “livingskinequivalents”areengineeredconstructs
composed of stratiﬁed squamous epithelial cells grown at an
air-liquid interface above a collagen-type matrix seeded with
dermal ﬁbroblasts [7]. These models have greatly improved
the ability of researchers to study the mechanisms of human
disease (including tumorigenesis and wound repair) in a
more biologically relevant in vitro system [8]. Regardless, the
complexityofwoundhealinginvivocannotbefullyrecreated
in a culture dish, and animal models are a necessary tool in
elucidating the underlying pathology of human disease.
In silico and computer-based models allow for large-
scale processing of vast data sets and simulation of myriad
conditions which would be diﬃcult to test otherwise. For
example, these methods have been utilized to study wound
healing, inﬂammatory responses, and drug permeability
acrossskin[9–11].Finiteelementmethodshavebeenapplied2 Journal of Biomedicine and Biotechnology
to study dynamic processes such as the role of mechanical
forces in scar formation and wound contracture [12, 13].
Nonetheless, these approaches do not obviate the need for
an in vivo biologic system in which to test predicted results
and outcomes.
Species ranging from rodents to nonhuman primates
have been utilized to study skin disease [14–16]. More
recently,thered Duroc pighas beenextensively validated asa
model for human skin pathology and is increasingly thought
of as the ideal large animal model to study cutaneous disease
due to its similarity to human epithelial architecture, nerve
density,vascularity,matrix components,andotherbiological
parameters [17–20]. However, swine are expensive to house
and maintain, molecular reagents are often not validated
for swine tissues, and the use of large animals for highly
investigational work is not practical.
The laboratory mouse remains by far the most com-
monly used animal model for biologic research. Mice are
easy to house and maintain, are economical, and a wide
variety of mouse-speciﬁc reagents are available for research
purposes. In addition, over a thousand mutant loci have
been generated in mice, and innovative transgenic tools
provide researchers with unparalleled opportunities to study
disease pathophysiology [21]. Hundreds of mouse models of
human disease exist, and in many cases the diseased gene of
interest is mutated in both human and mouse [22]. Thus,
the vast abundance of disease models, knockout strains, and
transgenic toolshave ensured thatmouse models will remain
highly relevant to the study of skin biology [23, 24]. This
paper will focus mainly on surgical models of pathologic
wound healing and their contribution to our understanding
of human wound repair.
2.MouseversusHumanWound Repair
Before we review several commonly used mouse models
to study wound repair, it is important to brieﬂy discuss
some major diﬀerences between mouse and human skin
(Table 1). Although mouse skin consists of three layers as
humanskindoes(i.e.,epidermis,dermis,hypodermis), there
are signiﬁcant diﬀerences in the anatomy and physiology
of each layer. Mouse skin is covered with dense hair that
undergoesa deﬁned cycleofhairgrowthas doeshumanhair:
anagen (growth), catagen (regression), and telogen (rest)
[25]. The hair cycle on the mouse dorsum progresses from
cranial to caudal, and its temporal characteristics can diﬀer
signiﬁcantly from various regions of the human body [26].
For example, the mouse hair cycle is about three weeks,
whereas hair cycles of the human scalp can last several
years [25]. Additionally, human hair is generally either vellus
(penetrates to the superﬁcial dermis and is unpigmented) or
terminal (penetrates intodeepdermisand is pigmented)and
exhibitsan androgen-sensitive switch from vellusto terminal
forms, properties not characteristic of mouse hair [25].
Mouse skin also lacks apocrine sweat glands and rete
ridges/dermal papillae, which are both found in human skin.
However, rete ridge-like structures may become apparent
during mouse wound healing and are often described as
“pseudoepitheliomatous” or “pseudocarcinomatous hyper-
plasia” [27]. Mouse skin is also unique in having a pan-
niculosus carnosus layer (a thin muscle layer found only as
the platysma of the neck in humans) which produces rapid
wound contraction following injury. In contrast, human
wounds heal via re-epithelialization and granulation tissue
formation, important diﬀerences to consider when assessing
the translational relevance of mouse studies. Another factor
to consider when designing mouse experiments is the
signiﬁcant gender diﬀerence in mouse skin anatomy and
physiology. For example, male skin is 40% stronger due
to a much thicker dermis, while female skin exhibits a
thicker epidermis and hypodermis [28]. Our laboratory has
also previously reported that mouse skin is signiﬁcantly
more compliant than human skin, which is important when
examining the mechanical environment of wound repair
[29]. Despite these numerous diﬀerences, mouse models
have contributed signiﬁcantly to our understanding of skin
biology and disease, and an awareness of these dissimilarities
will allow researchers to better evaluate and apply mouse-
based models of repair to human disease.
3.ExcisionalWound HealingModels
The treatment of chronic nonhealing wounds accounts for
a signiﬁcant proportion of healthcare expenditures [30].
Myriad factors contribute to impaired healing, including
deﬁcits in cell activity, inﬂammatory signaling, and matrix
assembly. The most commonly employed mouse model
used to study these processes is the excisional wound
model(Figure 1(a)).Typically,afull skinthicknessexcisional
wound is created on the dorsum of the mouse and extends
through the panniculosus carnosus. Wounds are then pho-
tographed regularly and wound closure is calculated based
on wound size relative to the original wound dimensions.
Our laboratory has described a splinted wound model
using silicone rings to prevent wound margin contracture,
thus better recapitulating the repair mechanisms underlying
human wound healing [31].
The beneﬁts of this common surgical model are numer-
ous. The necessary materials and techniques are relatively
simple,reproducible,andpracticalforexperimentsinvolving
a large sample size. The wound bed can be easily accessed
to apply topical agents (e.g., pharmaceuticals, cells, bioma-
terials) to study modulations of repair processes. Harvested
woundscanbeexaminedhistologicallyforboththeepithelial
gap (the quantiﬁable distance between the epithelial wound
margins) and granulation bed characteristics (recruited cell
populations, vascularity, matrix alterations). Thus, this sur-
gical mouse model remains an essential tool for researchers
studying cutaneous disease.
4.MouseModelsofCutaneousIschemia and
ReperfusionInjury
Neovascularization is a critical component ofnormal wound
healing, and impairments in this process are highly impli-
catedindiabeticandagedwoundhealing[32].However,newJournal of Biomedicine and Biotechnology 3
Table 1: Major diﬀerences between mouse and human skin.
Mouse Human
Hair cycle Approximately 3 weeks Highly variable, region-dependent
Epithelial architecture No rete ridges Rete ridges present
Apocrine sweat glands Not present in skin, extensive in mammary
glands
Present in axilla, inguinal, and perianal skin
regions
Biomechanical properties Thin, compliant, loose Thick, relatively stiﬀ, adherent to underlying
tissues
Hypodermal thickness Hair cycle-dependent Less variable
Subcutaneous muscle layer Present throughout as panniculosus
carnosus Present only in neck region as platysma
Major method of wound healing Contraction Granulation tissue formationand
re-epithelialization
blood vessel formation is a complex process, involving both
angiogenesis (sprouting of new vessels from existing ones)
and vasculogenesis (de novo formation of neovessels from
circulating endothelial progenitor cells). Signiﬁcant insight
into these processes has been provided by mouse models of
cutaneous ischemia. One of the most frequentlyused models
is the ischemic skin ﬂap model (Figure 1(b)). In this model,
a three-sided full skin thickness peninsular ﬂap is created
o nt h ed o r s u mo ft h em o u s ea n da ni m p e r m e a b l es i l i c o n e
membrane is placed directly underneath the skin ﬂap and
the ﬂap incisions are closed with suture. The silicone barrier
prevents neovascularization from the underlying wound bed
and ensures that the skin ﬂap is supplied on only one side
by the ﬂap pedicle, thereby creating a reproducible ischemic
gradientextendingfromtheproximal(nearesttothepedicle)
to the distal (most ischemic) portion of the ﬂap.
These models have been important in elucidating novel
mechanisms of blood vessel formation, speciﬁcally, the roles
ofischemicsignaling andvasculogenesisinwoundrepair.We
have previously employed this model to investigate the role
ofchemokine pathwaysin the recruitmentofprogenitorcells
to ischemic wounds [33]. Speciﬁcally, we demonstrated that
hypoxic wound gradients recruit systemic stem cells through
hypoxia-inducible factor (HIF)-1α-induced expression of
stromal cell-derived factor-1. Our laboratory also utilized
this model to demonstrate impairments in HIF-1α-mediated
vasculogenesis during aging [34] and the role of oxygen free
radicals in diabetic wound repair [35].
Ischemia-reperfusion models have also been developed
to study pressure ulcers, the treatment of which costs up to
$11 billionper year in the US [36]. The pathogenesis of pres-
sureulcersisthoughttobemediatedthroughinjuriouscycles
of ischemia and reperfusion, and models based on cyclical
magnetic compression have been described (Figure 1(c)),
allowing researchers to examine wound inﬂammation,
apoptosis and reactive oxygen-mediated signaling following
injury [37, 38]. Wassermann et al. recently described a
full thickness skin/muscle pressure ulcer model using a
metal disk implanted beneath the mouse gluteal muscle
and cyclical pressure applied with an external magnet
[39]. Although numerous models have been employed in
larger animals using friction, temperature, position, muscle
damage, pressure, and ischemia-reperfusion injury [40], the
practical beneﬁts of mouse-based pressure ulcer models
cannot be overlooked. Despite our limited knowledge of
pressure ulcer pathogenesis, the development of practical
small animal models represents a step toward improved
understanding of this clinically signiﬁcant disease.
5.Mouse Modelsof SkinFibrosis
Fibroproliferative diseases contribute to the majority of
deaths in the developed world [2]. In addition, skin ﬁbrosis
following burn and radiation injury, trauma, and surgery
causes a signiﬁcant degree of functional impairment and
aesthetic complications[41].Thelackofeﬀectiveantiﬁbrotic
therapies highlights our incomplete understanding of scar
pathophysiology. Various mouse models of skin ﬁbrosis have
been developed, but ﬁbrosis is induced by myriad agents
or modalities with diﬀering mechanisms which may not be
physiologically applicable to human scar formation.
Chemical injury models have been described using sub-
cutaneous injections of the sclerosing agents bleomycin or
vinyl chloride to mimic human diseases such as scleroderma
[42, 43]. Transgenic mice harboring genetic mutations (such
a st i g h ts k i nm i c eo ri n t e g r i na l p h a1n u l lm i c e )a n d
xenograft-induced activation of the mouse immune system
havealso beenusedasmodelsforhumanﬁbroticskindisease
[44]. Branding, scalding, and ﬂame injury models have
been employed to study cellular activation and recruitment
following burn injury [45, 46]. For example, Zhang et al.
utilized a mouse burn model to study the injury response
of circulating angiogenic cells and also examined these cells
in human burn injury patients [46]. Potential therapeutics
for radiation-induced ﬁbrosis have been studied in mice [47]
and scar models utilizing radiation injury in the tight skin
mouse have been developed [48].
Our laboratory recently described a mouse model of
hypertrophicscarformationbyapplyingexogenousmechan-
ical loads to incisions which otherwise heal with minimal
scar[29].Thismodelispredicatedontheclinicalobservation
that human incisions which heal under elevated tension
are prone to develop robust scarring, whereas skin injuries4 Journal of Biomedicine and Biotechnology
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Figure 1: Surgical mouse models of cutaneous disease. (a) Full thickness excisional wound models are commonly used to assess numerous
componentsofwoundhealingin vivo.Contractionofthe underlying panniculosuscarnosuscanbe minimizedwitha splinted woundmodel
(right) whereby wound repair proceeds mainly through granulation tissue formation and re-epithelialization similar to human skin repair.
(b) The ischemic ﬂap model produces a controlled gradient of ischemia based on the number and location of feeding blood vessels. Skin
regions furthest from the vessel/s are the most ischemic. (c) Cyclical pressure can be applied with opposing magnets and interpositioned
skin to mimic reperfusion/ischemia injury thought to drive pressure ulcer pathophysiology. (d) The application of exogenous mechanical
loading to mouse incisions results in increased wound ﬁbrosis similar to human hypertrophic scarring.
in areas under low tension rarely develop large scars [49,
50]. This model employs a distraction device mounted
onto the mouse dorsum and mechanical loads are applied
orthogonal to the healing incision (Figure 1(d)). Force levels
of 1.5N/mm2 to 2.7N/mm2 are applied during the early
proliferative phase of wound repair and are suﬃcient to
induce a signiﬁcant ﬁbrotic response for over six months
[29]. When this mechanical load model was applied to
transgenic mice with altered survival pathways, we were able
to identify putative intracellular targets in hypertrophic scar
formation [29].
6.Dorsal SkinFold ChamberModels
The dorsal skin fold chamber has been a well-established
model to examine vessel physiology in both normal and
pathologic states (Figure 2(a))[ 51]. In conjunction with
intravital microscopy, skin fold chamber models permit in
vivo assessment of vascular physiology over multiple time
scales. High-resolution real-time images can beobtainedand
haverevealednovelmechanisms ofhumanpathologysuchas
vascularembolicdisease [52].Sorgetal.utilizedadorsalskin
fold chamber model to examine mouse wound regenerationJournal of Biomedicine and Biotechnology 5
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Figure 2: Schematic of commonly employed surgical mouse models of human disease. (a) The dorsal skin fold chamber allows real-
time imaging of cutaneous physiology in high resolution when combined with intravital microscopy techniques (right). (b) Parabiotic
models permit researchers to investigate the role of circulating factors and/or cells from the donor parabiont in cutaneous wound repair.
( c )E n g i n e e r e dh u m a ns k i nc o n s t r u c t sc a nb eg r a f t e do n t oi m m u n o c o m p r o m i s e dm i c et os t u d yh u m a ns k i ne x p l a n tp h y s i o l o g yw i t h i na
living biologic (immunodeﬁcient) environment.
following full thickness skin injury [53]a n dt os t u d y
the eﬀects of erythropoietin on dermal regeneration [54].
Ichioka et al. developed a skin fold chamber model to study
theeﬀectsofischemia reperfusion onthemicrocirculationof
pedicled ﬂaps [55], and Park et al. examined arteriovenous
malformations in transgenic mice using these techniques
[56]. Continued improvements in intravital microscopy, cell
tracking, and biomolecular tracers will undoubtedly provide
further insight into novel mechanisms in wound healing.
7.ParabiosisModels
Parabiosis models involve the surgical joining of two mice
at their ﬂank skin to study the circulation of cells or
circulating factors between the two animals (Figure 2(b)).
Cross-circulation is generally established between the two
parabionts by several days through new vascular anasto-
moses [57]. This model was ﬁrst described by Bert in the
1860s and popularized by Sauerbruch and Heyde in early
1900s [58]. Since that time, numerous parabiosis models
have been developed to study cancer metastasis, circulatory
physiology, immunology, and metabolic diseases. In the
context of wound healing, recent studies have demonstrated
that circulating factors and systemic-derived cells play an
important role in numerous aspects of skin homeostasis and
repair.
Our laboratory utilized a parabiotic model to demon-
strate the participation of bone marrow-derived stem cells in
ischemic vasculogenesis and wound repair [59]. GFP+ mice
werepairedwithwild-typecounterpartsandGFP+cellswere
found to engraft in wildtype neovessels following ischemic
injury. Song et al. employed a similar strategy to characterize
the contribution of circulating cells to the repair of full6 Journal of Biomedicine and Biotechnology
Table 2: Surgical mouse models of cutaneous disease with select
references.
Mouse Model Human Disease
Relevance Select References
Excisional
Wound
Diabetes and obesity [31, 65, 66]
Aging [67, 68]
Obesity [69]
Ischemic Flap Diabetes [35]
Aging [34]
Pressure Ulcer Diabetes [37]
Decubitus ulcers [38, 39]
Mechanical
Load
Hypertrophic scar
formation [29]
Parabiosis
Diabetes, obesity [61, 62]
Ischemic wounds [59]
Scleroderma [63]
Aging [64]
Dorsal Skin
Fold Chamber
Arteriovenous
malformations [56]
Xenografting Donor graft integration [70]
Wound remodeling [71]
thickness excisional wounds [60]. They found substantial
involvement of circulating cells in various aspects of early
wound repair, including inﬂammation, mesenchymal dif-
ferentiation, and blood vessel formation. Parabiotic models
havealsobeenusedtohighlighttheimportanceofcirculating
factors in delayed wound healing in diabetic mice [61], to
study the relationship between obesity and diabetes [62],
to investigate the role of circulating ﬁbroblast precursors
in bleomycin-induced skin ﬁbrosis [63], and to examine
alterations in skin collagen remodeling with aging [64].
8.H umanSkinG raftM odels
For decades, researchers have transplanted human skin onto
the back of immunocompromised mice (Figure 2(c))t o
examine human skin explants in a more biologic environ-
ment [72, 73]. Geer et al. transplanted human engineered
skin onto athymic mice and tracked mouse contributions
to both human epithelial and dermal wound repair [70].
Rossio-Pasquier et al. examined species-speciﬁc epithelial-
mesenchymal interactionsinasimilarhumanskintransplant
model [74] and Guerret et al. grafted a multispecies skin
construct onto nude mice to characterize the remodeling
process as contributed to by human, mouse, and bovine
constituents [71]. These studies and numerous others
have allowed researchers to examine the integration and
remodeling of both natural and engineered skin constructs
in a living biologic environment. However, the requisite
inﬂammatory and immune responses in human wound
repair are necessarily attenuated in immunocompromised
mice, thus somewhat limiting the biological relevance of
these models.
9.Conclusion
In conclusion, numerous surgical models of wound healing
havebeendevelopedinthemouseand havegreatlyimproved
our understanding of wound repair in various disease states
(Table 2). Although each model system has its speciﬁc
advantages anddrawbacks, mouse models for human disease
have become an indispensible tool for researchers. Thus, a
familiarity with common mouse models of wound repair
and an awareness of their limitations will enable scientists
to develop research strategies with greater translational
potential.
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